Vaccine efficacy: Cervarix™17
| Endpoint | Number of women in vaccine group | Number HPV16 related | Number HPV18 related | Number of women in placebo group | Number HPV16 related | Number HPV18 related |
|---|---|---|---|---|---|---|
| ASCUS, abnormal squamous cells of unknown significance; CIN, cervical intra-epithelial neoplasia; HPV, human papillomavirus; LSIL, low grade squamous intra-epithelial lesion. | ||||||
| ASCUS | 505 | 1 | 1 | 497 | 32 | 17 |
| LSIL | 505 | 1 | 1 | 497 | 22 | 6 |
| CIN1+ | 481 | 0 | 0 | 481 | 8 | 0 |
| CIN2+ | 481 | 0 | 0 | 470 | 5 | 0 |